{"gene":"TOB1","run_date":"2026-06-10T10:51:55","timeline":{"discoveries":[{"year":1996,"finding":"TOB1 was identified as a novel protein that physically interacts with the receptor tyrosine kinase p185erbB2 (ErbB2) via its C-terminal half, as demonstrated by GST pull-down and reciprocal co-immunoprecipitation. The interaction with kinase-active p185erbB2 hampers TOB1-mediated growth suppression of NIH3T3 cells.","method":"GST pull-down, reciprocal co-immunoprecipitation, cell growth assay","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP and GST pull-down with functional growth suppression assay in the same study; foundational identification paper","pmids":["8632892"],"is_preprint":false},{"year":2000,"finding":"TOB1 (Tob) negatively regulates BMP/Smad signaling in osteoblasts by associating with receptor-regulated Smads (Smad1, 5, and 8) and colocalizing with them in nuclear bodies upon BMP2 stimulation. Tob overexpression represses BMP2-induced, Smad-mediated transcriptional activation. Mice with targeted deletion of tob have increased bone mass due to increased osteoblast numbers and elevated BMP2-induced orthotopic bone formation.","method":"Co-immunoprecipitation, immunofluorescence colocalization, transcriptional reporter assays, tob knockout mouse analysis","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (Co-IP, reporter assay, in vivo KO phenotype), replicated by subsequent studies","pmids":["11163184"],"is_preprint":false},{"year":2001,"finding":"TOB1 associates with Smad2 and Smad4 in T cells and enhances Smad DNA-binding on the −105 negative regulatory element of the IL-2 promoter, thereby inhibiting IL-2 transcription and maintaining T cell quiescence. Forced expression of Tob inhibited T cell proliferation; antisense suppression augmented CD3-mediated responses.","method":"Co-immunoprecipitation, EMSA (Smad DNA-binding), transcriptional reporter assay, antisense oligonucleotide loss-of-function, proliferation assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, EMSA, reporter assay and gain/loss-of-function in the same study; replicated by subsequent work","pmids":["11694881"],"is_preprint":false},{"year":1999,"finding":"The N-terminal half of TOB1 (and Tob2) associates with human Caf1 (a component of the CCR4 transcription factor complex), and Caf1 in turn associates with cyclin-dependent kinases, implicating TOB1 in cell cycle regulation through this interaction.","method":"Co-immunoprecipitation, protein interaction assays, cell cycle analysis","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP demonstrated interaction; single lab, two methods","pmids":["10602502"],"is_preprint":false},{"year":2002,"finding":"TOB1 is phosphorylated at Ser152, Ser154, and Ser164 by ERK1 and ERK2 upon growth factor stimulation. Non-phosphorylatable Tob (serine-to-alanine mutants) efficiently suppresses Ras-induced transformation and growth-factor-induced proliferation, while phosphomimetic mutants (serine-to-glutamate) are less inhibitory. Tob inhibits cell growth by suppressing cyclin D1 expression, and this is canceled by ERK1/2-mediated phosphorylation. Tob functions upstream of Rb.","method":"In vitro kinase assay, site-directed mutagenesis, cell proliferation and transformation assays, serum starvation experiments with tob−/− cells, cyclin D1 reporter/expression analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro kinase assay with mutagenesis, genetic (KO) and cellular functional assays, multiple orthogonal methods in one study","pmids":["12050114"],"is_preprint":false},{"year":2002,"finding":"TOB1 is identified as an ERK2-interacting protein and a substrate of ERK MAPK (ERK2) and JNK/SAPK (JNK2) in vitro. An ERK-docking site resides in the N-terminal portion of Tob; phosphorylation sites are in the C-terminal stretch. ERK phosphorylation negatively regulates Tob's anti-proliferative function.","method":"Two-hybrid screening, in vitro kinase assay, cell cycle analysis with phosphomimetic mutants","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with mutagenesis, confirmed by cellular studies; single lab","pmids":["12151396"],"is_preprint":false},{"year":2001,"finding":"p90rsk1 associates with and phosphorylates TOB1 on serines and threonines in vitro and in vivo, suggesting p90rsk1 (downstream of receptor tyrosine kinases) regulates Tob function through phosphorylation.","method":"In vitro kinase assay, co-immunoprecipitation, chromatographic co-fractionation","journal":"Genes to cells","confidence":"Medium","confidence_rationale":"Tier 1–2 / Weak — in vitro kinase assay and Co-IP performed in single lab; indirect evidence for in vivo phosphorylation","pmids":["11260258"],"is_preprint":false},{"year":2003,"finding":"TOB1 acts as a transcriptional corepressor by suppressing cyclin D1 promoter activity through an interaction with histone deacetylase. Tob knockout mice are prone to spontaneous tumor formation, and cyclin D1 mRNA is increased in the absence of Tob.","method":"Transcriptional reporter assay, co-immunoprecipitation with HDAC, tob−/− mouse tumor analysis, cyclin D1 mRNA measurement","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo KO phenotype combined with mechanistic reporter assay and Co-IP; replicated across multiple biological systems","pmids":["12756225"],"is_preprint":false},{"year":2003,"finding":"TOB1 interacts with inhibitory Smads 6 and 7 (identified by yeast two-hybrid screen), colocalizes with Smad6 at the plasma membrane, and enhances the interaction between Smad6 and activated BMP type I receptors, thereby inhibiting BMP signaling. Tob and Tob2 cooperate with Smad6 to inhibit BMP signaling in Xenopus embryonic explants and mammalian cells.","method":"Yeast two-hybrid screen, co-immunoprecipitation, immunofluorescence colocalization, Xenopus embryo assay, BMP reporter assay","journal":"Mechanisms of development","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods including yeast two-hybrid, Co-IP, in vivo Xenopus, and cell-based reporter assays","pmids":["12782279"],"is_preprint":false},{"year":2004,"finding":"TOB1 is a nuclear protein imported via a nuclear localization signal (NLS). Mutation of the NLS impairs nuclear localization and antiproliferative activity. In oncogenic ErbB2-transformed cells, nuclear export of Tob is facilitated through a nuclear export signal (NES), reducing antiproliferative activity.","method":"NLS/NES mutagenesis, immunofluorescence microscopy, cell cycle analysis","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Moderate — NLS/NES mutagenesis with direct localization and functional readout; single lab, two orthogonal methods","pmids":["15235587"],"is_preprint":false},{"year":2004,"finding":"TOB1 contains a functional NES in residues 2–14 and a bipartite NLS in residues 18–40, enabling nucleocytoplasmic shuttling. Cytoplasmic localization or nucleocytoplasmic shuttling (rather than strict nuclear localization) is important for the antiproliferative function of Tob, as addition of a strong NLS weakens its cell cycle inhibitory activity.","method":"Leptomycin B treatment, NES/NLS mutagenesis with exogenous strong NLS/NES constructs, cell cycle analysis","journal":"Experimental cell research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — chemical inhibitor + mutagenesis + functional cell cycle assay, single lab; consistent with parallel study (PMID 15235587)","pmids":["15051490"],"is_preprint":false},{"year":2005,"finding":"TOB1 interacts with poly(A)-binding protein (PABP) and inducible PABP (iPABP) through the C-terminal region of iPABP. Tob abrogates iPABP-enhanced translation of IL-2 mRNA in vitro and suppresses IL-2 production in cells. Tob was co-immunoprecipitated with iPABP from anergic human T cells.","method":"Expression library screening, co-immunoprecipitation, GST pull-down, in vitro translation assay, overexpression in NIH3T3 cells","journal":"Genes to cells","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — GST pull-down, Co-IP, in vitro translation assay with functional outcome; single lab with orthogonal methods","pmids":["15676026"],"is_preprint":false},{"year":2006,"finding":"TOB1 is degraded via the ubiquitin-proteasome pathway through Skp2, an F-box substrate-targeting subunit of the SCF ubiquitin ligase complex. Skp2 interacts with Tob1 and facilitates its ubiquitination in intact cells and in vitro. F-box or LRR deletion mutants of Skp2 neither bind nor ubiquitinate Tob1. Tob1 is stabilized in Skp2−/− cells.","method":"Co-immunoprecipitation, in vitro ubiquitination assay, Skp2 knockout fibroblasts, Skp2 knockdown (siRNA), cyclin D1 expression assay","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro ubiquitination, Co-IP, genetic KO and siRNA knockdown with consistent functional readouts; multiple orthogonal methods","pmids":["16951159"],"is_preprint":false},{"year":2002,"finding":"TOB1 (and BTG1, BTG2, Tob2) are degraded by the ubiquitin-proteasome system. The C-terminal region of Tob is necessary and sufficient to confer instability; C-terminal truncation stabilizes the protein.","method":"Proteasome inhibitor treatment, co-expression with ubiquitin, truncation mutant analysis, GFP fusion stability assay","journal":"European journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological inhibitor and mutagenesis with ubiquitination readout; single lab","pmids":["12135500"],"is_preprint":false},{"year":2007,"finding":"Human TOB1 enhances mRNA deadenylation in vivo by simultaneously interacting with the CCR4-CAF1 deadenylase complex and cytoplasmic poly(A)-binding protein PABPC1 via distinct protein motifs. Interaction with PABPC1 is necessary for TOB1's deadenylation-enhancing effect. TOB1 colocalizes with P-bodies as shown by immunofluorescence.","method":"GST pull-down, co-immunoprecipitation, mutagenesis mapping of interaction motifs, mRNA decay assay (Tet-off pulse-chase), immunofluorescence microscopy","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (Co-IP, GST pull-down, mutagenesis, functional mRNA decay assay, colocalization); single lab with rigorous controls","pmids":["17785442"],"is_preprint":false},{"year":2008,"finding":"TOB1 associates with the CCR4-NOT deadenylase complex; the C-terminal half of Tob interacts with Cnot1 (core protein of CCR4-NOT). Tob suppresses the deadenylase activity associated with the CCR4-NOT complex in vitro.","method":"Proteomics (stable cell line + mass spectrometry), co-immunoprecipitation, in vitro deadenylase activity assay","journal":"Cancer science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — proteomics identification confirmed by Co-IP, in vitro enzyme assay; single lab","pmids":["18377426"],"is_preprint":false},{"year":2009,"finding":"Crystal structure of the N-terminal region of TOB1 bound to human Caf1 (hCaf1) was determined. Tob exhibits a novel fold; hCaf1 resembles yeast Pop2 and human PARN catalytic domain. Both Box A and Box B of Tob mediate the association with hCaf1. The deadenylase activity of Caf1 is not critical, but complex formation between Tob and Caf1 is crucial for cell growth inhibition. Caf1 tethers Tob to the CCR4-Not complex, and Tob gathers poly(A)-binding proteins at its C-terminal region to exert antiproliferative activity.","method":"X-ray crystallography, cell growth assays with wild-type and mutant proteins, protein interaction analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure determination combined with mutagenesis-based functional assays; provides mechanistic resolution of domain-function relationships","pmids":["19276069"],"is_preprint":false},{"year":2010,"finding":"Quantitative NMR and biochemical analyses revealed that Tob consists of a structured N-terminal BTG-Tob domain (which binds Caf1) and an unstructured C-terminal region containing two PAM2 motifs (which bind PABPC1 PABC domain with Kd ~20 µM). Given that cellular eRF3 levels (~4–5 µM) exceed Tob levels (<0.2 µM), a thermodynamic competition model was proposed in which Tob-Caf1 recruits deadenylase to the poly(A) tail following translation termination.","method":"NMR spectroscopy, Western blot quantification, binding affinity measurement (Kd determination)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure and quantitative binding analysis provide thermodynamic mechanistic detail; single lab","pmids":["20595394"],"is_preprint":false},{"year":2011,"finding":"TOB1 binds directly to CPEB3 (a sequence-specific RNA-binding protein) via the C-terminal RNA-binding domain of CPEB3 interacting with the C-terminal unstructured region of Tob. Tob then recruits Caf1 deadenylase to form a CPEB3-Tob-Caf1 ternary complex, mediating accelerated deadenylation and decay of CPEB3 target mRNA. Dominant-negative mutants of either Caf1 or Tob abrogated CPEB3-accelerated deadenylation.","method":"Co-immunoprecipitation, GST pull-down, in vitro deadenylation assay, dominant-negative mutant analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods including protein interaction mapping, in vitro functional assay, and dominant-negative validation; single lab","pmids":["21336257"],"is_preprint":false},{"year":2012,"finding":"The anti-proliferative activity of TOB1 (and BTG/TOB family members) is mediated through interactions with Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-Not complex. Surface-exposed residues of TOB1 mediating this interaction were characterized, and a Caf1a/Caf1b-binding mutant of TOB1 lost anti-proliferative activity. TOB1 regulation of mRNA abundance and translation is also dependent on Caf1a/Caf1b but not on Ccr4a/Ccr4b or non-catalytic CNOT1/CNOT3 subunits.","method":"Site-directed mutagenesis, cell proliferation assays, mRNA abundance assay, translation assay, siRNA knockdown of Ccr4-Not subunits","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Strong — mutagenesis-defined interaction domain, multiple functional readouts (proliferation, mRNA, translation), subunit-specific dissection via siRNA; single lab with orthogonal methods","pmids":["23236473"],"is_preprint":false},{"year":2012,"finding":"TOB1 tethering to mRNA directly promotes mRNA deadenylation via recruitment of CAF1-CCR4; this activity is independent of the three ERK phosphorylation serines that regulate antiproliferative activity, suggesting TOB1 arrests cell growth through at least two distinct mechanisms. TOB1 and TOB2 are functionally interchangeable in deadenylation.","method":"Tethering assay (MS2-based), mRNA deadenylation and decay monitoring, phosphorylation site mutagenesis, cell growth assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — direct tethering/functional mRNA decay assay with mutagenesis; single lab, multiple orthogonal methods","pmids":["22252318"],"is_preprint":false},{"year":2012,"finding":"TOB1 associates directly with Caf1 and Cdk1 (cyclin-dependent kinase 1) in the liver, and modulates Cdk1 kinase activity. Tob1 protein decreases after 2/3 hepatectomy via posttranscriptional mechanisms, and deletion of Tob1 accelerates liver regeneration and hepatocyte proliferation.","method":"Co-immunoprecipitation, kinase activity assay, Tob1−/− mouse hepatectomy model, hepatocyte proliferation assay","journal":"The Journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and kinase assay, supported by in vivo KO model; single lab","pmids":["20513747"],"is_preprint":false},{"year":2001,"finding":"PMA-induced phosphorylation of MARCKS increases its binding affinity to TOB1, competing with ErbB2 for TOB1 binding, resulting in decreased Tob–ErbB2 interaction and subsequent ErbB2 activation in breast cancer cells.","method":"Co-immunoprecipitation, PMA stimulation assay, domain mapping (PSD of MARCKS)","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single Co-IP approach replicated across multiple conditions; single lab","pmids":["11327693"],"is_preprint":false},{"year":2005,"finding":"TOB1 and Tob2 suppress steroid hormone receptor-dependent transcriptional activation in osteoblastic cells. TOB1 inhibits nuclear foci formation of dihydrotestosterone-bound androgen receptor (AR), as visualized by GFP-AR confocal microscopy. This effect does not require the LXXLL motif in Tob.","method":"Luciferase reporter assay, GFP-AR live-cell confocal microscopy, mutagenesis of LXXLL motif","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay and direct imaging with mutagenesis control; single lab","pmids":["15664454"],"is_preprint":false},{"year":2008,"finding":"TOB1 activates the mouse Dpp2 (dipeptidyl peptidase 2) promoter in concert with KLF2, suggesting TOB1 functions as a transcriptional co-activator in the context of lymphocyte quiescence maintenance.","method":"Promoter-reporter assay (luciferase), endogenous transcript measurement","journal":"Molecular immunology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single reporter assay, single lab, no direct binding or co-IP data shown","pmids":["18555530"],"is_preprint":false},{"year":2012,"finding":"Cdc7 (DNA replication-initiating kinase) phosphorylates TOB1 and interacts with it to inhibit Cul4-DDB1(Cdt2)-dependent ubiquitination and proteasomal degradation of Tob. In response to mild DNA damage, Tob levels increase through both transcription and Cdc7-mediated protein stabilization, and this inhibits pro-apoptotic signaling. Cells lacking Cdc7 show increased Tob ubiquitination and undergo apoptosis after mild DNA damage.","method":"In vitro kinase assay, co-immunoprecipitation, ubiquitination assay, siRNA knockdown of Cdc7, cell viability assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro kinase assay, Co-IP, and ubiquitination assay with genetic knockdown validation; single lab, multiple orthogonal methods","pmids":["23066029"],"is_preprint":false},{"year":2008,"finding":"Proteasome-dependent degradation of TOB1 triggered by UV irradiation is required for UV-induced apoptosis. Degradation-resistant Tob (with short C-terminal deletions or a tag sequence) impairs UV-induced apoptosis. siRNA knockdown of Tob results in frequent apoptosis even at sub-apoptotic UV doses in a p53-independent manner. tob−/− mice and MEFs are hypersensitive to UV irradiation.","method":"Proteasome inhibitor assay, C-terminal deletion/tag mutants, siRNA knockdown, tob−/− mouse/MEF analysis, apoptosis assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic (KO, siRNA, mutants) and pharmacological approaches with in vitro and in vivo validation; single lab","pmids":["18850001"],"is_preprint":false},{"year":2014,"finding":"Arsenite-induced oxidative stress inhibits mRNA deadenylation primarily through proteolytic degradation of TOB1 (and Pan3). siRNA knockdown of Tob and Pan3 recapitulates global stabilization of the mRNA poly(A) tail observed during arsenite stress, establishing Tob as a critical mediator of stress-induced deadenylation inhibition.","method":"siRNA knockdown, poly(A) tail length assay, protein degradation assay, arsenite treatment","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA phenocopy of stress condition with functional poly(A) readout; single lab","pmids":["25446091"],"is_preprint":false},{"year":2015,"finding":"TOB1 and TOB2 inhibit proliferation of mouse embryonic stem cells via degradation of Id3 mRNA (a BMP4-signaling target). Tob1−/−, Tob2−/−, and Tob1/2 double KO ESCs grew faster than wild-type ESCs without losing pluripotency.","method":"Knockout ESC generation, proliferation assay, mRNA stability/abundance measurement for Id3","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with mechanistic mRNA target identification; single lab","pmids":["25951976"],"is_preprint":false},{"year":2021,"finding":"TOB1 associates with Smad4/5 to induce expression of ID2, which in turn restrains Th1/Th17 cell differentiation, thereby blocking intestinal mucosal inflammation in IBD. Tob1−/− mice showed severe colitis; reconstitution with Tob1−/− CD4+ T cells recapitulated this. RNA sequencing identified ID2 as the functional target of TOB1.","method":"Co-immunoprecipitation (TOB1-Smad4/5), lentiviral overexpression/knockdown, Tob1−/− mouse colitis models (TNBS enema, Rag1−/− reconstitution), RNA sequencing","journal":"Cellular and molecular gastroenterology and hepatology","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP for protein interaction, multiple in vivo genetic models, RNA-seq for downstream target identification; single lab with multiple orthogonal methods","pmids":["34920145"],"is_preprint":false},{"year":1997,"finding":"Tob1 protein is localized to the nucleus and contains a sequence rich in proline and glutamine typical of transcription factors. The mouse tob gene lacks introns in its coding region and is ubiquitously expressed. The ATTTA motif in the 3'-UTR is characteristic of immediate early genes.","method":"Molecular cloning, Northern blot, sequence analysis","journal":"Gene","confidence":"Low","confidence_rationale":"Tier 4 / Weak — sequence analysis and expression data only; no direct functional experiment","pmids":["9210596"],"is_preprint":false},{"year":2015,"finding":"TOB1 localization is mainly cytoplasmic in pancreatic cancer cells. Foxa2 overexpression significantly enhanced TOB1 promoter activity by binding to the TOB1 promoter (luciferase reporter assay), placing Foxa2 as a transcriptional activator of TOB1.","method":"Dual-luciferase reporter assay, immunofluorescence localization","journal":"Cancer medicine","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single reporter assay and localization imaging; single lab, limited mechanistic depth","pmids":["31891232"],"is_preprint":false},{"year":2015,"finding":"TOB1 is associated with P-body marker Dcp2 in round spermatids and oocytes, as shown by co-immunofluorescence and protein co-expression analysis. TOB1 protein is highly expressed in round spermatids and oocytes, consistent with a post-transcriptional regulatory role in germ cells.","method":"Immunofluorescence, RT-ddPCR, co-localization microscopy","journal":"Cell and tissue research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — colocalization by immunofluorescence without functional validation of Tob1-Dcp2 interaction; single study","pmids":["26662055"],"is_preprint":false}],"current_model":"TOB1 is an antiproliferative protein that inhibits cell growth through at least two mechanistically distinct pathways: (1) as a transcriptional corepressor, it associates with receptor-regulated Smads (Smad1/2/4/5/8) and inhibitory Smads (Smad6/7) to suppress BMP/TGF-β signaling, with Smad4/5-dependent ID2 induction restraining Th17 differentiation, and recruits HDAC to suppress cyclin D1 transcription; (2) in the cytoplasm, it simultaneously binds Caf1 (CNOT7/CNOT8) deadenylase subunits of the CCR4-NOT complex (via its N-terminal BTG domain) and poly(A)-binding protein PABPC1 (via C-terminal PAM2 motifs), thereby recruiting deadenylase activity to the 3′ poly(A) tail to promote mRNA decay—a function further specified by interaction with CPEB3 for targeted mRNA regulation. TOB1 nucleo-cytoplasmic shuttling is governed by an N-terminal NES (residues 2–14) and a bipartite NLS (residues 18–40), and its anti-proliferative activity requires cytoplasmic access. Its stability and activity are regulated by phosphorylation: ERK1/2 and p90rsk1 phosphorylate Tob at C-terminal serines to inactivate its anti-proliferative function, while Skp2-SCF and Cul4-DDB1(Cdt2) E3 ubiquitin ligases mediate its proteasomal degradation—the latter being antagonized by Cdc7 kinase during the DNA damage response."},"narrative":{"mechanistic_narrative":"TOB1 is an antiproliferative protein that restrains cell growth through two mechanistically distinct activities: control of mRNA stability in the cytoplasm and transcriptional corepression in the nucleus [PMID:19276069, PMID:12756225]. As an adaptor for mRNA decay, TOB1 uses its structured N-terminal BTG-Tob domain to bind the Caf1 deadenylase subunits CNOT7/CNOT8 of the CCR4-NOT complex, while its unstructured C-terminal region carries two PAM2 motifs that engage cytoplasmic poly(A)-binding protein PABPC1; by bridging these partners it recruits deadenylase activity to the 3' poly(A) tail and accelerates mRNA decay, localizing to P-bodies in doing so [PMID:17785442, PMID:19276069, PMID:20595394]. This tethered deadenylation is the basis of its growth-suppressive role, and a Caf1-binding mutant loses antiproliferative activity [PMID:19276069, PMID:23236473]; the activity directs decay of specific transcripts, including CPEB3-targeted mRNAs through a CPEB3-TOB1-Caf1 ternary complex and Id3 mRNA in embryonic stem cells [PMID:21336257, PMID:25951976]. In a parallel nuclear pathway, TOB1 associates with receptor-regulated Smads (Smad1/5/8) and inhibitory Smads (Smad6/7) to suppress BMP/TGF-beta signaling, with Smad4/5-dependent ID2 induction restraining Th17 differentiation and intestinal inflammation, and it represses cyclin D1 transcription via histone deacetylase recruitment to act upstream of Rb [PMID:11163184, PMID:12782279, PMID:34920145, PMID:12756225, PMID:12050114]. TOB1 function is gated by phosphorylation: ERK1/2 and p90rsk1 phosphorylate C-terminal serines (Ser152/154/164) to inactivate its antiproliferative output, and the deadenylation activity is separable from these sites [PMID:12050114, PMID:12151396, PMID:22252318]. Its abundance is controlled by ubiquitin-proteasome turnover through Skp2-SCF and Cul4-DDB1(Cdt2) ligases, the latter antagonized by Cdc7 kinase to stabilize TOB1 during the DNA damage response and block apoptosis [PMID:16951159, PMID:23066029, PMID:18850001]. Nucleocytoplasmic shuttling governed by an N-terminal NES and a bipartite NLS positions TOB1 for its cytoplasmic function, which requires cytoplasmic access [PMID:15235587, PMID:15051490].","teleology":[{"year":1996,"claim":"Established TOB1 as a growth-suppressing protein and linked it to receptor tyrosine kinase signaling by identifying its physical association with ErbB2.","evidence":"GST pull-down, reciprocal Co-IP, and growth suppression assay in NIH3T3 cells","pmids":["8632892"],"confidence":"High","gaps":["Did not define the biochemical mechanism of growth suppression","ErbB2 binding region mapped only to the C-terminal half"]},{"year":1999,"claim":"Connected TOB1 to the CCR4 deadenylase machinery and cell cycle control by mapping the Caf1 interaction to the N-terminal half.","evidence":"Co-IP and protein interaction assays with cell cycle analysis","pmids":["10602502"],"confidence":"Medium","gaps":["Functional consequence of Caf1 binding for mRNA decay not demonstrated","Single lab, two methods"]},{"year":2000,"claim":"Defined a nuclear, signaling-suppressive function by showing TOB1 binds receptor-regulated Smads and restrains BMP-driven osteoblast proliferation in vivo.","evidence":"Co-IP, immunofluorescence, reporter assays, and tob knockout mouse bone phenotype","pmids":["11163184"],"confidence":"High","gaps":["Whether Smad binding reflects corepressor activity at target promoters not resolved","Relationship to cytoplasmic deadenylation function unaddressed"]},{"year":2001,"claim":"Extended the Smad-associated function to immune quiescence, showing TOB1 enhances Smad DNA-binding at the IL-2 promoter to suppress T cell proliferation.","evidence":"Co-IP, EMSA, reporter assay, antisense loss-of-function and proliferation assays in T cells","pmids":["11694881"],"confidence":"High","gaps":["Direct DNA contact by TOB1 vs Smad-mediated effect not separated"]},{"year":2001,"claim":"Began defining phospho-regulation of TOB1 by identifying p90rsk1 as a binding kinase downstream of receptor tyrosine kinases.","evidence":"In vitro kinase assay, Co-IP, chromatographic co-fractionation","pmids":["11260258"],"confidence":"Medium","gaps":["In vivo phosphorylation evidence indirect","Functional readout of p90rsk1 phosphorylation not established"]},{"year":2002,"claim":"Established ERK1/2 phosphorylation of C-terminal serines as the switch that inactivates TOB1's antiproliferative function, placing TOB1 upstream of Rb via cyclin D1 suppression.","evidence":"In vitro kinase assay, S-to-A/S-to-E mutagenesis, transformation and proliferation assays, tob-/- cells, cyclin D1 analysis","pmids":["12050114","12151396"],"confidence":"High","gaps":["Mechanism linking phosphorylation to loss of cyclin D1 repression not resolved","Whether phosphorylation affects deadenylation not addressed at this stage"]},{"year":2002,"claim":"Identified the C-terminal region as the determinant of TOB1's proteasomal instability, initiating the picture of regulated turnover.","evidence":"Proteasome inhibitor, ubiquitin co-expression, truncation/GFP-fusion stability assays","pmids":["12135500"],"confidence":"Medium","gaps":["Responsible E3 ligase not identified","Degron sequence not mapped"]},{"year":2003,"claim":"Showed TOB1 acts as a transcriptional corepressor recruiting HDAC to the cyclin D1 promoter, with loss causing tumor predisposition.","evidence":"Reporter assay, Co-IP with HDAC, tob-/- tumor analysis, cyclin D1 mRNA measurement","pmids":["12756225"],"confidence":"High","gaps":["Direct promoter occupancy by TOB1 not shown","Whether HDAC recruitment is Smad-dependent unclear"]},{"year":2003,"claim":"Broadened the Smad axis by showing TOB1 binds inhibitory Smads 6/7 and enhances Smad6 docking to BMP receptors to inhibit signaling.","evidence":"Yeast two-hybrid, Co-IP, colocalization, Xenopus embryo and BMP reporter assays","pmids":["12782279"],"confidence":"High","gaps":["Quantitative contribution relative to R-Smad binding not resolved"]},{"year":2004,"claim":"Defined nucleocytoplasmic shuttling via an N-terminal NES and bipartite NLS and established that cytoplasmic access is required for antiproliferative activity.","evidence":"Leptomycin B, NES/NLS mutagenesis with strong exogenous signals, immunofluorescence, cell cycle analysis","pmids":["15235587","15051490"],"confidence":"High","gaps":["Cytoplasmic target driving growth arrest not yet identified at this point","Regulation of shuttling by signaling incompletely defined"]},{"year":2005,"claim":"Linked TOB1 to translational control by showing it binds poly(A)-binding proteins and abrogates iPABP-enhanced IL-2 mRNA translation.","evidence":"Expression library screen, Co-IP, GST pull-down, in vitro translation, anergic T cell Co-IP","pmids":["15676026"],"confidence":"High","gaps":["Whether the effect is on translation vs deadenylation not separated here"]},{"year":2007,"claim":"Unified the cytoplasmic mechanism, showing TOB1 simultaneously bridges CCR4-CAF1 and PABPC1 via distinct motifs to enhance deadenylation at P-bodies.","evidence":"GST pull-down, Co-IP, motif mutagenesis, Tet-off mRNA decay assay, immunofluorescence","pmids":["17785442"],"confidence":"High","gaps":["In vivo target transcripts not yet identified","Quantitative kinetics of recruitment not measured"]},{"year":2009,"claim":"Provided structural resolution of the TOB1-Caf1 interface and showed complex formation, not Caf1 catalysis, is what matters for growth inhibition.","evidence":"X-ray crystallography of N-terminal TOB1 bound to hCaf1, plus mutant growth assays","pmids":["19276069"],"confidence":"High","gaps":["Structure of the C-terminal PABPC1-binding region not in this work"]},{"year":2010,"claim":"Quantified the binding architecture and proposed a thermodynamic competition model for recruiting deadenylase to the poly(A) tail after translation termination.","evidence":"NMR spectroscopy, Western quantification, Kd determination","pmids":["20595394"],"confidence":"High","gaps":["Competition model with eRF3 not validated in cells","Single lab"]},{"year":2011,"claim":"Demonstrated target-specific decay by showing TOB1 forms a CPEB3-TOB1-Caf1 ternary complex to accelerate deadenylation of CPEB3 target mRNAs.","evidence":"Co-IP, GST pull-down, in vitro deadenylation, dominant-negative mutants","pmids":["21336257"],"confidence":"High","gaps":["Endogenous CPEB3 target transcripts not enumerated"]},{"year":2012,"claim":"Separated TOB1's two activities, showing tethered deadenylation depends on Caf1a/Caf1b and is independent of the ERK phosphorylation sites controlling antiproliferation.","evidence":"MS2 tethering and decay assays, subunit-specific siRNA, mutagenesis, proliferation and translation assays","pmids":["23236473","22252318"],"confidence":"High","gaps":["How the two mechanisms are coordinated within a cell not resolved"]},{"year":2012,"claim":"Connected TOB1 to a tissue-level proliferative checkpoint by showing it binds Caf1 and Cdk1 in liver and restrains hepatocyte regeneration.","evidence":"Co-IP, kinase activity assay, Tob1-/- hepatectomy model","pmids":["20513747"],"confidence":"Medium","gaps":["Direct vs deadenylation-mediated effect on Cdk1 unclear","Single lab"]},{"year":2012,"claim":"Identified the Cul4-DDB1(Cdt2) degradation route and its antagonism by Cdc7, linking TOB1 stability to survival during DNA damage.","evidence":"In vitro kinase assay, Co-IP, ubiquitination assay, Cdc7 siRNA, viability assay","pmids":["23066029"],"confidence":"High","gaps":["Pro-apoptotic signals suppressed by stabilized TOB1 not fully defined"]},{"year":2006,"claim":"Identified Skp2-SCF as a primary E3 ligase for TOB1, coupling its degradation to cyclin D1 regulation.","evidence":"Co-IP, in vitro ubiquitination, Skp2-/- fibroblasts, siRNA, cyclin D1 assay","pmids":["16951159"],"confidence":"High","gaps":["Phospho-dependence of Skp2 recognition not fully mapped"]},{"year":2014,"claim":"Established TOB1 as a stress-responsive node, showing its degradation underlies arsenite-induced inhibition of global mRNA deadenylation.","evidence":"siRNA phenocopy, poly(A) tail assay, protein degradation assay under arsenite","pmids":["25446091"],"confidence":"Medium","gaps":["Protease responsible for stress degradation not identified","Single lab"]},{"year":2015,"claim":"Tied TOB1-driven decay to a specific developmental program by showing Id3 mRNA degradation limits embryonic stem cell proliferation.","evidence":"Tob1/Tob2 knockout ESCs, proliferation and Id3 mRNA stability assays","pmids":["25951976"],"confidence":"Medium","gaps":["Whether Id3 is a direct vs indirect target not fully resolved"]},{"year":2021,"claim":"Linked the Smad axis to an in vivo immune phenotype, showing TOB1-Smad4/5 induce ID2 to restrain Th1/Th17 differentiation and protect against colitis.","evidence":"Co-IP, lentiviral perturbation, Tob1-/- colitis models, RNA-seq","pmids":["34920145"],"confidence":"High","gaps":["Direct binding of TOB1-Smad complex at the ID2 locus not shown"]},{"year":null,"claim":"How the nuclear corepressor and cytoplasmic deadenylase functions are integrated, and what governs the choice between them in a given cell context, remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No unified model coordinating shuttling, phosphorylation state, and the two effector pathways","Genome-wide endogenous mRNA target set incompletely defined","Whether Smad/HDAC corepression and deadenylation regulate overlapping gene sets unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[14,16,18]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[15,16,11]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[7,2,8]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[20]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[10,14,31]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,9,30]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[14,32]}],"pathway":[{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[14,16,18]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,8,4]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[7,4,21]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2,29]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[7,2]}],"complexes":["CCR4-NOT deadenylase complex"],"partners":["CNOT7","CNOT8","PABPC1","CPEB3","SMAD4","SMAD6","ERBB2","SKP2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P50616","full_name":"Protein Tob1","aliases":["Transducer of erbB-2 1"],"length_aa":345,"mass_kda":38.2,"function":"Anti-proliferative protein; the function is mediated by association with deadenylase subunits of the CCR4-NOT complex (PubMed:23236473, PubMed:8632892). Mediates CPEB3-accelerated mRNA deadenylation by binding to CPEB3 and recruiting CNOT7 which leads to target mRNA deadenylation and decay (PubMed:21336257)","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/P50616/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TOB1","classification":"Not Classified","n_dependent_lines":5,"n_total_lines":1208,"dependency_fraction":0.0041390728476821195},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TOB1","total_profiled":1310},"omim":[{"mim_id":"607396","title":"TRANSDUCER OF ERBB2, 2; TOB2","url":"https://www.omim.org/entry/607396"},{"mim_id":"605523","title":"TRANSDUCER OF ERBB2, 1; TOB1","url":"https://www.omim.org/entry/605523"},{"mim_id":"224700","title":"EBSTEIN ANOMALY","url":"https://www.omim.org/entry/224700"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TOB1"},"hgnc":{"alias_symbol":["TOB","TROB","APRO5"],"prev_symbol":["TROB1"]},"alphafold":{"accession":"P50616","domains":[{"cath_id":"3.90.640.90","chopping":"1-114","consensus_level":"medium","plddt":97.6861,"start":1,"end":114}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P50616","model_url":"https://alphafold.ebi.ac.uk/files/AF-P50616-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P50616-F1-predicted_aligned_error_v6.png","plddt_mean":66.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TOB1","jax_strain_url":"https://www.jax.org/strain/search?query=TOB1"},"sequence":{"accession":"P50616","fasta_url":"https://rest.uniprot.org/uniprotkb/P50616.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P50616/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P50616"}},"corpus_meta":[{"pmid":"11163184","id":"PMC_11163184","title":"Negative regulation of BMP/Smad signaling by Tob in osteoblasts.","date":"2000","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/11163184","citation_count":262,"is_preprint":false},{"pmid":"19746446","id":"PMC_19746446","title":"The mammalian anti-proliferative BTG/Tob protein family.","date":"2010","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19746446","citation_count":247,"is_preprint":false},{"pmid":"11694881","id":"PMC_11694881","title":"Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells.","date":"2001","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11694881","citation_count":224,"is_preprint":false},{"pmid":"11377414","id":"PMC_11377414","title":"In search of a function for the TIS21/PC3/BTG1/TOB family.","date":"2001","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11377414","citation_count":216,"is_preprint":false},{"pmid":"11267995","id":"PMC_11267995","title":"The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?","date":"2001","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11267995","citation_count":197,"is_preprint":false},{"pmid":"8632892","id":"PMC_8632892","title":"Tob, a novel protein that interacts with p185erbB2, is associated with anti-proliferative activity.","date":"1996","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8632892","citation_count":179,"is_preprint":false},{"pmid":"17785442","id":"PMC_17785442","title":"Human TOB, an antiproliferative transcription factor, is a poly(A)-binding protein-dependent positive regulator of cytoplasmic mRNA deadenylation.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17785442","citation_count":138,"is_preprint":false},{"pmid":"10602502","id":"PMC_10602502","title":"Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases.","date":"1999","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10602502","citation_count":129,"is_preprint":false},{"pmid":"12050114","id":"PMC_12050114","title":"Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation.","date":"2002","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12050114","citation_count":119,"is_preprint":false},{"pmid":"22496419","id":"PMC_22496419","title":"The C-terminal domain of Fcj1 is required for formation of crista junctions and interacts with the TOB/SAM complex in mitochondria.","date":"2012","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/22496419","citation_count":103,"is_preprint":false},{"pmid":"12756225","id":"PMC_12756225","title":"Mice lacking a transcriptional corepressor Tob are predisposed to cancer.","date":"2003","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12756225","citation_count":101,"is_preprint":false},{"pmid":"9632145","id":"PMC_9632145","title":"ANA, a novel member of Tob/BTG1 family, is expressed in the ventricular zone of the developing central nervous system.","date":"1998","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9632145","citation_count":97,"is_preprint":false},{"pmid":"19276069","id":"PMC_19276069","title":"Structural basis for the antiproliferative activity of the Tob-hCaf1 complex.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19276069","citation_count":90,"is_preprint":false},{"pmid":"20111053","id":"PMC_20111053","title":"Mdm10 as a dynamic constituent of the TOB/SAM complex directs coordinated assembly of Tom40.","date":"2010","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/20111053","citation_count":85,"is_preprint":false},{"pmid":"19828319","id":"PMC_19828319","title":"BTG/TOB factors impact deadenylases.","date":"2009","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/19828319","citation_count":82,"is_preprint":false},{"pmid":"16479543","id":"PMC_16479543","title":"Differential mechanisms of microparticle transfer toB cells and monocytes: anti-inflammatory propertiesof microparticles.","date":"2006","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16479543","citation_count":81,"is_preprint":false},{"pmid":"32406432","id":"PMC_32406432","title":"Exosomal miRNA-486-5p derived from rheumatoid arthritis fibroblast-like synoviocytes induces osteoblast differentiation through the Tob1/BMP/Smad pathway.","date":"2020","source":"Biomaterials science","url":"https://pubmed.ncbi.nlm.nih.gov/32406432","citation_count":74,"is_preprint":false},{"pmid":"11856371","id":"PMC_11856371","title":"Interaction of PRMT1 with BTG/TOB proteins in cell signalling: molecular analysis and functional aspects.","date":"2002","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/11856371","citation_count":73,"is_preprint":false},{"pmid":"21336257","id":"PMC_21336257","title":"Anti-proliferative protein Tob negatively regulates CPEB3 target by recruiting Caf1 deadenylase.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/21336257","citation_count":69,"is_preprint":false},{"pmid":"15676026","id":"PMC_15676026","title":"Interaction of anti-proliferative protein Tob with poly(A)-binding protein and inducible poly(A)-binding protein: implication of Tob in translational control.","date":"2005","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/15676026","citation_count":64,"is_preprint":false},{"pmid":"23236473","id":"PMC_23236473","title":"The anti-proliferative activity of BTG/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-not complex.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23236473","citation_count":64,"is_preprint":false},{"pmid":"10995567","id":"PMC_10995567","title":"Cloning of PC3B, a novel member of the PC3/BTG/TOB family of growth inhibitory genes, highly expressed in the olfactory epithelium.","date":"2000","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/10995567","citation_count":64,"is_preprint":false},{"pmid":"15590639","id":"PMC_15590639","title":"Assembly of the TOB complex of mitochondria.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15590639","citation_count":62,"is_preprint":false},{"pmid":"12151396","id":"PMC_12151396","title":"Identification of the Anti-proliferative protein Tob as a MAPK substrate.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12151396","citation_count":61,"is_preprint":false},{"pmid":"10625537","id":"PMC_10625537","title":"A novel member of the tob family of proteins controls sexual fate in Caenorhabditis elegans germ cells.","date":"2000","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10625537","citation_count":61,"is_preprint":false},{"pmid":"16951159","id":"PMC_16951159","title":"Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16951159","citation_count":52,"is_preprint":false},{"pmid":"22710759","id":"PMC_22710759","title":"Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting β‑catenin signaling.","date":"2012","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22710759","citation_count":51,"is_preprint":false},{"pmid":"12372467","id":"PMC_12372467","title":"Altered expression of a cell-cycle suppressor gene, Tob-1, in endometriotic cells by cDNA array analyses.","date":"2002","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/12372467","citation_count":51,"is_preprint":false},{"pmid":"28556940","id":"PMC_28556940","title":"Three TOB1-related YABBY genes are required to maintain proper function of the spikelet and branch meristems in rice.","date":"2017","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/28556940","citation_count":51,"is_preprint":false},{"pmid":"15235587","id":"PMC_15235587","title":"Nuclear localization of Tob is important for regulation of its antiproliferative activity.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15235587","citation_count":50,"is_preprint":false},{"pmid":"12135500","id":"PMC_12135500","title":"Antiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome system.","date":"2002","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12135500","citation_count":48,"is_preprint":false},{"pmid":"14643028","id":"PMC_14643028","title":"Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer.","date":"2003","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/14643028","citation_count":48,"is_preprint":false},{"pmid":"17304515","id":"PMC_17304515","title":"Tob genes in development and homeostasis.","date":"2007","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/17304515","citation_count":47,"is_preprint":false},{"pmid":"12782279","id":"PMC_12782279","title":"Tob proteins enhance inhibitory Smad-receptor interactions to repress BMP signaling.","date":"2003","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/12782279","citation_count":43,"is_preprint":false},{"pmid":"22252318","id":"PMC_22252318","title":"Evidence providing new insights into TOB-promoted deadenylation and supporting a link between TOB's deadenylation-enhancing and antiproliferative activities.","date":"2012","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22252318","citation_count":43,"is_preprint":false},{"pmid":"23797093","id":"PMC_23797093","title":"Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity.","date":"2013","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23797093","citation_count":40,"is_preprint":false},{"pmid":"11429045","id":"PMC_11429045","title":"Association of ANA, a member of the antiproliferative Tob family proteins, with a Caf1 component of the CCR4 transcriptional regulatory complex.","date":"2001","source":"Japanese journal of cancer research : Gann","url":"https://pubmed.ncbi.nlm.nih.gov/11429045","citation_count":39,"is_preprint":false},{"pmid":"24307243","id":"PMC_24307243","title":"IL-4-induced gene 1 maintains high Tob1 expression that contributes to TCR unresponsiveness in human T helper 17 cells.","date":"2013","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24307243","citation_count":38,"is_preprint":false},{"pmid":"15766599","id":"PMC_15766599","title":"Phosphorylation and inactivation of Tob contributes to the progression of papillary carcinoma of the thyroid.","date":"2005","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/15766599","citation_count":37,"is_preprint":false},{"pmid":"22158108","id":"PMC_22158108","title":"Suppression of human lung cancer cell proliferation and metastasis in vitro by the transducer of ErbB-2.1 (TOB1).","date":"2011","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/22158108","citation_count":36,"is_preprint":false},{"pmid":"19569230","id":"PMC_19569230","title":"TOB suppresses breast cancer tumorigenesis.","date":"2009","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19569230","citation_count":36,"is_preprint":false},{"pmid":"32307083","id":"PMC_32307083","title":"LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/32307083","citation_count":35,"is_preprint":false},{"pmid":"15100414","id":"PMC_15100414","title":"Tob deficiency superenhances osteoblastic activity after ovariectomy to block estrogen deficiency-induced osteoporosis.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15100414","citation_count":35,"is_preprint":false},{"pmid":"31814731","id":"PMC_31814731","title":"MiR-32-5p Regulates Radiosensitization, Migration And Invasion Of Colorectal Cancer Cells By Targeting TOB1 Gene.","date":"2019","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31814731","citation_count":33,"is_preprint":false},{"pmid":"18377426","id":"PMC_18377426","title":"Interaction of antiproliferative protein Tob with the CCR4-NOT deadenylase complex.","date":"2008","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/18377426","citation_count":32,"is_preprint":false},{"pmid":"26824451","id":"PMC_26824451","title":"TOB1 Deficiency Enhances the Effect of Bone Marrow-Derived Mesenchymal Stem Cells on Tendon-Bone Healing in a Rat Rotator Cuff Repair Model.","date":"2016","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26824451","citation_count":29,"is_preprint":false},{"pmid":"28947212","id":"PMC_28947212","title":"MicroRNA-590 promotes pathogenic Th17 cell differentiation through targeting Tob1 and is associated with multiple sclerosis.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28947212","citation_count":28,"is_preprint":false},{"pmid":"11327693","id":"PMC_11327693","title":"Tob-mediated cross-talk between MARCKS phosphorylation and ErbB-2 activation.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11327693","citation_count":28,"is_preprint":false},{"pmid":"30529155","id":"PMC_30529155","title":"MicroRNA-371a-3p promotes progression of gastric cancer by targeting TOB1.","date":"2018","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/30529155","citation_count":27,"is_preprint":false},{"pmid":"15730870","id":"PMC_15730870","title":"The negative cell cycle regulator, Tob (transducer of ErbB-2), is a multifunctional protein involved in hippocampus-dependent learning and memory.","date":"2005","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15730870","citation_count":27,"is_preprint":false},{"pmid":"26694352","id":"PMC_26694352","title":"Transducer of ERBB2.1 (TOB1) as a Tumor Suppressor: A Mechanistic Perspective.","date":"2015","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26694352","citation_count":26,"is_preprint":false},{"pmid":"20513747","id":"PMC_20513747","title":"Tob1 is a constitutively expressed repressor of liver regeneration.","date":"2010","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20513747","citation_count":25,"is_preprint":false},{"pmid":"16414345","id":"PMC_16414345","title":"The negative cell cycle regulator, Tob (transducer of ErbB-2), is involved in motor skill learning.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16414345","citation_count":25,"is_preprint":false},{"pmid":"19270514","id":"PMC_19270514","title":"Tob, a member of the APRO family, regulates immunological quiescence and tumor suppression.","date":"2009","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/19270514","citation_count":24,"is_preprint":false},{"pmid":"26165839","id":"PMC_26165839","title":"Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation.","date":"2015","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/26165839","citation_count":24,"is_preprint":false},{"pmid":"30210918","id":"PMC_30210918","title":"Long noncoding RNA TOB1-AS1, an epigenetically silenced gene, functioned as a novel tumor suppressor by sponging miR-27b in cervical cancer.","date":"2018","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30210918","citation_count":23,"is_preprint":false},{"pmid":"31772627","id":"PMC_31772627","title":"TOB1-AS1 suppresses non-small cell lung cancer cell migration and invasion through a ceRNA network.","date":"2019","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31772627","citation_count":23,"is_preprint":false},{"pmid":"21533545","id":"PMC_21533545","title":"Identification of novel subregions of LOH in gastric cancer and analysis of the HIC1 and TOB1 tumor suppressor genes in these subregions.","date":"2011","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/21533545","citation_count":23,"is_preprint":false},{"pmid":"9286591","id":"PMC_9286591","title":"Sequence and developmental expression of AmphiTob, an amphioxus homolog of vertebrate Tob in the PC3/BTG1/Tob family of tumor suppressor genes.","date":"1997","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/9286591","citation_count":23,"is_preprint":false},{"pmid":"16163674","id":"PMC_16163674","title":"The BTG/TOB family protein TIS21 regulates stage-specific proliferation of developing thymocytes.","date":"2005","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16163674","citation_count":23,"is_preprint":false},{"pmid":"20595394","id":"PMC_20595394","title":"Quantitative characterization of Tob interactions provides the thermodynamic basis for translation termination-coupled deadenylase regulation.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20595394","citation_count":23,"is_preprint":false},{"pmid":"32407174","id":"PMC_32407174","title":"LncRNA NR2F1-AS1 Regulates miR-371a-3p/TOB1 Axis to Suppress Proliferation of Colorectal Cancer Cells.","date":"2020","source":"Cancer biotherapy & radiopharmaceuticals","url":"https://pubmed.ncbi.nlm.nih.gov/32407174","citation_count":21,"is_preprint":false},{"pmid":"21571637","id":"PMC_21571637","title":"Phosphorylation state of a Tob/BTG protein, FOG-3, regulates initiation and maintenance of the Caenorhabditis elegans sperm fate program.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21571637","citation_count":21,"is_preprint":false},{"pmid":"34920145","id":"PMC_34920145","title":"TOB1 Blocks Intestinal Mucosal Inflammation Through Inducing ID2-Mediated Suppression of Th1/Th17 Cell Immune Responses in IBD.","date":"2021","source":"Cellular and molecular gastroenterology and hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/34920145","citation_count":20,"is_preprint":false},{"pmid":"23589165","id":"PMC_23589165","title":"Enhanced radiosensitivity of NSCLC cells by transducer of erbB2.1 (TOB1) through modulation of the MAPK/ERK pathway.","date":"2013","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/23589165","citation_count":20,"is_preprint":false},{"pmid":"21980517","id":"PMC_21980517","title":"The Neurospora crassa TOB complex: analysis of the topology and function of Tob38 and Tob37.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21980517","citation_count":20,"is_preprint":false},{"pmid":"15664454","id":"PMC_15664454","title":"Tob proteins suppress steroid hormone receptor-mediated transcriptional activation.","date":"2005","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/15664454","citation_count":20,"is_preprint":false},{"pmid":"29088861","id":"PMC_29088861","title":"Decreased TOB1 expression and increased phosphorylation of nuclear TOB1 promotes gastric cancer.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29088861","citation_count":19,"is_preprint":false},{"pmid":"25951976","id":"PMC_25951976","title":"BTG/Tob family members Tob1 and Tob2 inhibit proliferation of mouse embryonic stem cells via Id3 mRNA degradation.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25951976","citation_count":19,"is_preprint":false},{"pmid":"17883950","id":"PMC_17883950","title":"Adenovirus-mediated expression of Tob1 sensitizes breast cancer cells to ionizing radiation.","date":"2007","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/17883950","citation_count":19,"is_preprint":false},{"pmid":"9210596","id":"PMC_9210596","title":"Cloning and characterization of the mouse tob gene.","date":"1997","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9210596","citation_count":19,"is_preprint":false},{"pmid":"16217684","id":"PMC_16217684","title":"Expression of sarcotoxin IA gene via a root-specific tob promoter enhanced host resistance against parasitic weeds in tomato plants.","date":"2005","source":"Plant cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/16217684","citation_count":19,"is_preprint":false},{"pmid":"15743474","id":"PMC_15743474","title":"Repression of anti-proliferative factor Tob1 in osteoarthritic cartilage.","date":"2005","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/15743474","citation_count":18,"is_preprint":false},{"pmid":"11260258","id":"PMC_11260258","title":"A serine/threonine kinase p90rsk1 phosphorylates the anti-proliferative protein Tob.","date":"2001","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/11260258","citation_count":18,"is_preprint":false},{"pmid":"15051490","id":"PMC_15051490","title":"Regulation of subcellular localization of the antiproliferative protein Tob by its nuclear export signal and bipartite nuclear localization signal sequences.","date":"2004","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/15051490","citation_count":18,"is_preprint":false},{"pmid":"25071870","id":"PMC_25071870","title":"The role of antiproliferative gene Tob1 in the immune system.","date":"2014","source":"Clinical & experimental neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/25071870","citation_count":17,"is_preprint":false},{"pmid":"16445768","id":"PMC_16445768","title":"Tob is a potential marker gene for the basal layer of the epidermis and is stably expressed in human primary keratinocytes.","date":"2006","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/16445768","citation_count":17,"is_preprint":false},{"pmid":"35154457","id":"PMC_35154457","title":"Exosomal miR-552-5p promotes tumorigenesis and disease progression via the PTEN/TOB1 axis in gastric cancer.","date":"2022","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35154457","citation_count":17,"is_preprint":false},{"pmid":"11893628","id":"PMC_11893628","title":"cAMP and in vivo hypoxia induce tob, ifr1, and fos expression in erythroid cells of the chick embryo.","date":"2002","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11893628","citation_count":17,"is_preprint":false},{"pmid":"23066029","id":"PMC_23066029","title":"Inhibition of DNA damage-induced apoptosis through Cdc7-mediated stabilization of Tob.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23066029","citation_count":16,"is_preprint":false},{"pmid":"18555530","id":"PMC_18555530","title":"Lymphocyte quiescence factor Dpp2 is transcriptionally activated by KLF2 and TOB1.","date":"2008","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18555530","citation_count":16,"is_preprint":false},{"pmid":"17318539","id":"PMC_17318539","title":"Nitrite metabolism in Debaryomyces hansenii TOB-Y7, a yeast strain involved in tobacco fermentation.","date":"2007","source":"Applied microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/17318539","citation_count":16,"is_preprint":false},{"pmid":"33247598","id":"PMC_33247598","title":"Expression of TOB/BTG family members in patients with inflammatory bowel disease.","date":"2021","source":"Scandinavian journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33247598","citation_count":15,"is_preprint":false},{"pmid":"31799657","id":"PMC_31799657","title":"Long non-coding RNA TOB1-AS1 modulates cell proliferation, apoptosis, migration and invasion through miR-23a/NEU1 axis via Wnt/b-catenin pathway in gastric cancer.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31799657","citation_count":15,"is_preprint":false},{"pmid":"17164348","id":"PMC_17164348","title":"Twisted gastrulation (Tsg) is regulated by Tob and enhances TGF-beta signaling in activated T lymphocytes.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17164348","citation_count":15,"is_preprint":false},{"pmid":"33786619","id":"PMC_33786619","title":"Identification of miR‑25‑3p as a tumor biomarker: Regulation of cellular functions via TOB1 in breast cancer.","date":"2021","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/33786619","citation_count":15,"is_preprint":false},{"pmid":"12054157","id":"PMC_12054157","title":"Enhancing effect of Tob deficiency on bone formation is specific to bone morphogenetic protein-induced osteogenesis.","date":"2002","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/12054157","citation_count":15,"is_preprint":false},{"pmid":"30930080","id":"PMC_30930080","title":"The discovery of shorter synthetic proteolytic peptides derived from Tob1 protein.","date":"2019","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/30930080","citation_count":13,"is_preprint":false},{"pmid":"24945807","id":"PMC_24945807","title":"Nfatc2 and Tob1 have non-overlapping function in T cell negative regulation and tumorigenesis.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24945807","citation_count":12,"is_preprint":false},{"pmid":"18850001","id":"PMC_18850001","title":"Proteasome-mediated degradation of Tob is pivotal for triggering UV-induced apoptosis.","date":"2008","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/18850001","citation_count":12,"is_preprint":false},{"pmid":"26377349","id":"PMC_26377349","title":"Tob1 enhances radiosensitivity of breast cancer cells involving the JNK and p38 pathways.","date":"2015","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/26377349","citation_count":12,"is_preprint":false},{"pmid":"25446091","id":"PMC_25446091","title":"Arsenite inhibits mRNA deadenylation through proteolytic degradation of Tob and Pan3.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25446091","citation_count":11,"is_preprint":false},{"pmid":"22797076","id":"PMC_22797076","title":"C. elegans FOG-3/Tob can either promote or inhibit germline proliferation, depending on gene dosage and genetic context.","date":"2012","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/22797076","citation_count":11,"is_preprint":false},{"pmid":"18657378","id":"PMC_18657378","title":"Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model.","date":"2008","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/18657378","citation_count":11,"is_preprint":false},{"pmid":"23756562","id":"PMC_23756562","title":"Overexpression of TOB1 confers radioprotection to bronchial epithelial cells through the MAPK/ERK pathway.","date":"2013","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/23756562","citation_count":10,"is_preprint":false},{"pmid":"31891232","id":"PMC_31891232","title":"TOB1 suppresses proliferation in K-Ras wild-type pancreatic cancer.","date":"2019","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31891232","citation_count":9,"is_preprint":false},{"pmid":"26662055","id":"PMC_26662055","title":"Tob1 is expressed in developing and adult gonads and is associated with the P-body marker, Dcp2.","date":"2015","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/26662055","citation_count":9,"is_preprint":false},{"pmid":"36917096","id":"PMC_36917096","title":"Chimeric Tobramycin-Based Adjuvant TOB-TOB-CIP Potentiates Fluoroquinolone and β-Lactam Antibiotics against Multidrug-Resistant Pseudomonas aeruginosa.","date":"2023","source":"ACS infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/36917096","citation_count":9,"is_preprint":false},{"pmid":"35465266","id":"PMC_35465266","title":"The Overexpression of TOB1 Induces Autophagy in Gastric Cancer Cells by Secreting Exosomes.","date":"2022","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/35465266","citation_count":9,"is_preprint":false},{"pmid":"35186488","id":"PMC_35186488","title":"Involvement of TOB1 on autophagy in gastric cancer AGS cells via decreasing the activation of AKT/mTOR signaling pathway.","date":"2022","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/35186488","citation_count":9,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48639,"output_tokens":8361,"usd":0.135666,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18057,"output_tokens":5951,"usd":0.11953,"stage2_stop_reason":"end_turn"},"total_usd":0.255196,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"TOB1 was identified as a novel protein that physically interacts with the receptor tyrosine kinase p185erbB2 (ErbB2) via its C-terminal half, as demonstrated by GST pull-down and reciprocal co-immunoprecipitation. The interaction with kinase-active p185erbB2 hampers TOB1-mediated growth suppression of NIH3T3 cells.\",\n      \"method\": \"GST pull-down, reciprocal co-immunoprecipitation, cell growth assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP and GST pull-down with functional growth suppression assay in the same study; foundational identification paper\",\n      \"pmids\": [\"8632892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"TOB1 (Tob) negatively regulates BMP/Smad signaling in osteoblasts by associating with receptor-regulated Smads (Smad1, 5, and 8) and colocalizing with them in nuclear bodies upon BMP2 stimulation. Tob overexpression represses BMP2-induced, Smad-mediated transcriptional activation. Mice with targeted deletion of tob have increased bone mass due to increased osteoblast numbers and elevated BMP2-induced orthotopic bone formation.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence colocalization, transcriptional reporter assays, tob knockout mouse analysis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (Co-IP, reporter assay, in vivo KO phenotype), replicated by subsequent studies\",\n      \"pmids\": [\"11163184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"TOB1 associates with Smad2 and Smad4 in T cells and enhances Smad DNA-binding on the −105 negative regulatory element of the IL-2 promoter, thereby inhibiting IL-2 transcription and maintaining T cell quiescence. Forced expression of Tob inhibited T cell proliferation; antisense suppression augmented CD3-mediated responses.\",\n      \"method\": \"Co-immunoprecipitation, EMSA (Smad DNA-binding), transcriptional reporter assay, antisense oligonucleotide loss-of-function, proliferation assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, EMSA, reporter assay and gain/loss-of-function in the same study; replicated by subsequent work\",\n      \"pmids\": [\"11694881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The N-terminal half of TOB1 (and Tob2) associates with human Caf1 (a component of the CCR4 transcription factor complex), and Caf1 in turn associates with cyclin-dependent kinases, implicating TOB1 in cell cycle regulation through this interaction.\",\n      \"method\": \"Co-immunoprecipitation, protein interaction assays, cell cycle analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP demonstrated interaction; single lab, two methods\",\n      \"pmids\": [\"10602502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"TOB1 is phosphorylated at Ser152, Ser154, and Ser164 by ERK1 and ERK2 upon growth factor stimulation. Non-phosphorylatable Tob (serine-to-alanine mutants) efficiently suppresses Ras-induced transformation and growth-factor-induced proliferation, while phosphomimetic mutants (serine-to-glutamate) are less inhibitory. Tob inhibits cell growth by suppressing cyclin D1 expression, and this is canceled by ERK1/2-mediated phosphorylation. Tob functions upstream of Rb.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis, cell proliferation and transformation assays, serum starvation experiments with tob−/− cells, cyclin D1 reporter/expression analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro kinase assay with mutagenesis, genetic (KO) and cellular functional assays, multiple orthogonal methods in one study\",\n      \"pmids\": [\"12050114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"TOB1 is identified as an ERK2-interacting protein and a substrate of ERK MAPK (ERK2) and JNK/SAPK (JNK2) in vitro. An ERK-docking site resides in the N-terminal portion of Tob; phosphorylation sites are in the C-terminal stretch. ERK phosphorylation negatively regulates Tob's anti-proliferative function.\",\n      \"method\": \"Two-hybrid screening, in vitro kinase assay, cell cycle analysis with phosphomimetic mutants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with mutagenesis, confirmed by cellular studies; single lab\",\n      \"pmids\": [\"12151396\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"p90rsk1 associates with and phosphorylates TOB1 on serines and threonines in vitro and in vivo, suggesting p90rsk1 (downstream of receptor tyrosine kinases) regulates Tob function through phosphorylation.\",\n      \"method\": \"In vitro kinase assay, co-immunoprecipitation, chromatographic co-fractionation\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Weak — in vitro kinase assay and Co-IP performed in single lab; indirect evidence for in vivo phosphorylation\",\n      \"pmids\": [\"11260258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TOB1 acts as a transcriptional corepressor by suppressing cyclin D1 promoter activity through an interaction with histone deacetylase. Tob knockout mice are prone to spontaneous tumor formation, and cyclin D1 mRNA is increased in the absence of Tob.\",\n      \"method\": \"Transcriptional reporter assay, co-immunoprecipitation with HDAC, tob−/− mouse tumor analysis, cyclin D1 mRNA measurement\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo KO phenotype combined with mechanistic reporter assay and Co-IP; replicated across multiple biological systems\",\n      \"pmids\": [\"12756225\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TOB1 interacts with inhibitory Smads 6 and 7 (identified by yeast two-hybrid screen), colocalizes with Smad6 at the plasma membrane, and enhances the interaction between Smad6 and activated BMP type I receptors, thereby inhibiting BMP signaling. Tob and Tob2 cooperate with Smad6 to inhibit BMP signaling in Xenopus embryonic explants and mammalian cells.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, immunofluorescence colocalization, Xenopus embryo assay, BMP reporter assay\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods including yeast two-hybrid, Co-IP, in vivo Xenopus, and cell-based reporter assays\",\n      \"pmids\": [\"12782279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TOB1 is a nuclear protein imported via a nuclear localization signal (NLS). Mutation of the NLS impairs nuclear localization and antiproliferative activity. In oncogenic ErbB2-transformed cells, nuclear export of Tob is facilitated through a nuclear export signal (NES), reducing antiproliferative activity.\",\n      \"method\": \"NLS/NES mutagenesis, immunofluorescence microscopy, cell cycle analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — NLS/NES mutagenesis with direct localization and functional readout; single lab, two orthogonal methods\",\n      \"pmids\": [\"15235587\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TOB1 contains a functional NES in residues 2–14 and a bipartite NLS in residues 18–40, enabling nucleocytoplasmic shuttling. Cytoplasmic localization or nucleocytoplasmic shuttling (rather than strict nuclear localization) is important for the antiproliferative function of Tob, as addition of a strong NLS weakens its cell cycle inhibitory activity.\",\n      \"method\": \"Leptomycin B treatment, NES/NLS mutagenesis with exogenous strong NLS/NES constructs, cell cycle analysis\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — chemical inhibitor + mutagenesis + functional cell cycle assay, single lab; consistent with parallel study (PMID 15235587)\",\n      \"pmids\": [\"15051490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TOB1 interacts with poly(A)-binding protein (PABP) and inducible PABP (iPABP) through the C-terminal region of iPABP. Tob abrogates iPABP-enhanced translation of IL-2 mRNA in vitro and suppresses IL-2 production in cells. Tob was co-immunoprecipitated with iPABP from anergic human T cells.\",\n      \"method\": \"Expression library screening, co-immunoprecipitation, GST pull-down, in vitro translation assay, overexpression in NIH3T3 cells\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — GST pull-down, Co-IP, in vitro translation assay with functional outcome; single lab with orthogonal methods\",\n      \"pmids\": [\"15676026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TOB1 is degraded via the ubiquitin-proteasome pathway through Skp2, an F-box substrate-targeting subunit of the SCF ubiquitin ligase complex. Skp2 interacts with Tob1 and facilitates its ubiquitination in intact cells and in vitro. F-box or LRR deletion mutants of Skp2 neither bind nor ubiquitinate Tob1. Tob1 is stabilized in Skp2−/− cells.\",\n      \"method\": \"Co-immunoprecipitation, in vitro ubiquitination assay, Skp2 knockout fibroblasts, Skp2 knockdown (siRNA), cyclin D1 expression assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro ubiquitination, Co-IP, genetic KO and siRNA knockdown with consistent functional readouts; multiple orthogonal methods\",\n      \"pmids\": [\"16951159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"TOB1 (and BTG1, BTG2, Tob2) are degraded by the ubiquitin-proteasome system. The C-terminal region of Tob is necessary and sufficient to confer instability; C-terminal truncation stabilizes the protein.\",\n      \"method\": \"Proteasome inhibitor treatment, co-expression with ubiquitin, truncation mutant analysis, GFP fusion stability assay\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological inhibitor and mutagenesis with ubiquitination readout; single lab\",\n      \"pmids\": [\"12135500\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Human TOB1 enhances mRNA deadenylation in vivo by simultaneously interacting with the CCR4-CAF1 deadenylase complex and cytoplasmic poly(A)-binding protein PABPC1 via distinct protein motifs. Interaction with PABPC1 is necessary for TOB1's deadenylation-enhancing effect. TOB1 colocalizes with P-bodies as shown by immunofluorescence.\",\n      \"method\": \"GST pull-down, co-immunoprecipitation, mutagenesis mapping of interaction motifs, mRNA decay assay (Tet-off pulse-chase), immunofluorescence microscopy\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (Co-IP, GST pull-down, mutagenesis, functional mRNA decay assay, colocalization); single lab with rigorous controls\",\n      \"pmids\": [\"17785442\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TOB1 associates with the CCR4-NOT deadenylase complex; the C-terminal half of Tob interacts with Cnot1 (core protein of CCR4-NOT). Tob suppresses the deadenylase activity associated with the CCR4-NOT complex in vitro.\",\n      \"method\": \"Proteomics (stable cell line + mass spectrometry), co-immunoprecipitation, in vitro deadenylase activity assay\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proteomics identification confirmed by Co-IP, in vitro enzyme assay; single lab\",\n      \"pmids\": [\"18377426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Crystal structure of the N-terminal region of TOB1 bound to human Caf1 (hCaf1) was determined. Tob exhibits a novel fold; hCaf1 resembles yeast Pop2 and human PARN catalytic domain. Both Box A and Box B of Tob mediate the association with hCaf1. The deadenylase activity of Caf1 is not critical, but complex formation between Tob and Caf1 is crucial for cell growth inhibition. Caf1 tethers Tob to the CCR4-Not complex, and Tob gathers poly(A)-binding proteins at its C-terminal region to exert antiproliferative activity.\",\n      \"method\": \"X-ray crystallography, cell growth assays with wild-type and mutant proteins, protein interaction analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure determination combined with mutagenesis-based functional assays; provides mechanistic resolution of domain-function relationships\",\n      \"pmids\": [\"19276069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Quantitative NMR and biochemical analyses revealed that Tob consists of a structured N-terminal BTG-Tob domain (which binds Caf1) and an unstructured C-terminal region containing two PAM2 motifs (which bind PABPC1 PABC domain with Kd ~20 µM). Given that cellular eRF3 levels (~4–5 µM) exceed Tob levels (<0.2 µM), a thermodynamic competition model was proposed in which Tob-Caf1 recruits deadenylase to the poly(A) tail following translation termination.\",\n      \"method\": \"NMR spectroscopy, Western blot quantification, binding affinity measurement (Kd determination)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure and quantitative binding analysis provide thermodynamic mechanistic detail; single lab\",\n      \"pmids\": [\"20595394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TOB1 binds directly to CPEB3 (a sequence-specific RNA-binding protein) via the C-terminal RNA-binding domain of CPEB3 interacting with the C-terminal unstructured region of Tob. Tob then recruits Caf1 deadenylase to form a CPEB3-Tob-Caf1 ternary complex, mediating accelerated deadenylation and decay of CPEB3 target mRNA. Dominant-negative mutants of either Caf1 or Tob abrogated CPEB3-accelerated deadenylation.\",\n      \"method\": \"Co-immunoprecipitation, GST pull-down, in vitro deadenylation assay, dominant-negative mutant analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods including protein interaction mapping, in vitro functional assay, and dominant-negative validation; single lab\",\n      \"pmids\": [\"21336257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The anti-proliferative activity of TOB1 (and BTG/TOB family members) is mediated through interactions with Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-Not complex. Surface-exposed residues of TOB1 mediating this interaction were characterized, and a Caf1a/Caf1b-binding mutant of TOB1 lost anti-proliferative activity. TOB1 regulation of mRNA abundance and translation is also dependent on Caf1a/Caf1b but not on Ccr4a/Ccr4b or non-catalytic CNOT1/CNOT3 subunits.\",\n      \"method\": \"Site-directed mutagenesis, cell proliferation assays, mRNA abundance assay, translation assay, siRNA knockdown of Ccr4-Not subunits\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mutagenesis-defined interaction domain, multiple functional readouts (proliferation, mRNA, translation), subunit-specific dissection via siRNA; single lab with orthogonal methods\",\n      \"pmids\": [\"23236473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TOB1 tethering to mRNA directly promotes mRNA deadenylation via recruitment of CAF1-CCR4; this activity is independent of the three ERK phosphorylation serines that regulate antiproliferative activity, suggesting TOB1 arrests cell growth through at least two distinct mechanisms. TOB1 and TOB2 are functionally interchangeable in deadenylation.\",\n      \"method\": \"Tethering assay (MS2-based), mRNA deadenylation and decay monitoring, phosphorylation site mutagenesis, cell growth assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct tethering/functional mRNA decay assay with mutagenesis; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"22252318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TOB1 associates directly with Caf1 and Cdk1 (cyclin-dependent kinase 1) in the liver, and modulates Cdk1 kinase activity. Tob1 protein decreases after 2/3 hepatectomy via posttranscriptional mechanisms, and deletion of Tob1 accelerates liver regeneration and hepatocyte proliferation.\",\n      \"method\": \"Co-immunoprecipitation, kinase activity assay, Tob1−/− mouse hepatectomy model, hepatocyte proliferation assay\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and kinase assay, supported by in vivo KO model; single lab\",\n      \"pmids\": [\"20513747\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"PMA-induced phosphorylation of MARCKS increases its binding affinity to TOB1, competing with ErbB2 for TOB1 binding, resulting in decreased Tob–ErbB2 interaction and subsequent ErbB2 activation in breast cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, PMA stimulation assay, domain mapping (PSD of MARCKS)\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single Co-IP approach replicated across multiple conditions; single lab\",\n      \"pmids\": [\"11327693\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TOB1 and Tob2 suppress steroid hormone receptor-dependent transcriptional activation in osteoblastic cells. TOB1 inhibits nuclear foci formation of dihydrotestosterone-bound androgen receptor (AR), as visualized by GFP-AR confocal microscopy. This effect does not require the LXXLL motif in Tob.\",\n      \"method\": \"Luciferase reporter assay, GFP-AR live-cell confocal microscopy, mutagenesis of LXXLL motif\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay and direct imaging with mutagenesis control; single lab\",\n      \"pmids\": [\"15664454\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TOB1 activates the mouse Dpp2 (dipeptidyl peptidase 2) promoter in concert with KLF2, suggesting TOB1 functions as a transcriptional co-activator in the context of lymphocyte quiescence maintenance.\",\n      \"method\": \"Promoter-reporter assay (luciferase), endogenous transcript measurement\",\n      \"journal\": \"Molecular immunology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single reporter assay, single lab, no direct binding or co-IP data shown\",\n      \"pmids\": [\"18555530\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Cdc7 (DNA replication-initiating kinase) phosphorylates TOB1 and interacts with it to inhibit Cul4-DDB1(Cdt2)-dependent ubiquitination and proteasomal degradation of Tob. In response to mild DNA damage, Tob levels increase through both transcription and Cdc7-mediated protein stabilization, and this inhibits pro-apoptotic signaling. Cells lacking Cdc7 show increased Tob ubiquitination and undergo apoptosis after mild DNA damage.\",\n      \"method\": \"In vitro kinase assay, co-immunoprecipitation, ubiquitination assay, siRNA knockdown of Cdc7, cell viability assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro kinase assay, Co-IP, and ubiquitination assay with genetic knockdown validation; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"23066029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Proteasome-dependent degradation of TOB1 triggered by UV irradiation is required for UV-induced apoptosis. Degradation-resistant Tob (with short C-terminal deletions or a tag sequence) impairs UV-induced apoptosis. siRNA knockdown of Tob results in frequent apoptosis even at sub-apoptotic UV doses in a p53-independent manner. tob−/− mice and MEFs are hypersensitive to UV irradiation.\",\n      \"method\": \"Proteasome inhibitor assay, C-terminal deletion/tag mutants, siRNA knockdown, tob−/− mouse/MEF analysis, apoptosis assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic (KO, siRNA, mutants) and pharmacological approaches with in vitro and in vivo validation; single lab\",\n      \"pmids\": [\"18850001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Arsenite-induced oxidative stress inhibits mRNA deadenylation primarily through proteolytic degradation of TOB1 (and Pan3). siRNA knockdown of Tob and Pan3 recapitulates global stabilization of the mRNA poly(A) tail observed during arsenite stress, establishing Tob as a critical mediator of stress-induced deadenylation inhibition.\",\n      \"method\": \"siRNA knockdown, poly(A) tail length assay, protein degradation assay, arsenite treatment\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA phenocopy of stress condition with functional poly(A) readout; single lab\",\n      \"pmids\": [\"25446091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TOB1 and TOB2 inhibit proliferation of mouse embryonic stem cells via degradation of Id3 mRNA (a BMP4-signaling target). Tob1−/−, Tob2−/−, and Tob1/2 double KO ESCs grew faster than wild-type ESCs without losing pluripotency.\",\n      \"method\": \"Knockout ESC generation, proliferation assay, mRNA stability/abundance measurement for Id3\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with mechanistic mRNA target identification; single lab\",\n      \"pmids\": [\"25951976\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TOB1 associates with Smad4/5 to induce expression of ID2, which in turn restrains Th1/Th17 cell differentiation, thereby blocking intestinal mucosal inflammation in IBD. Tob1−/− mice showed severe colitis; reconstitution with Tob1−/− CD4+ T cells recapitulated this. RNA sequencing identified ID2 as the functional target of TOB1.\",\n      \"method\": \"Co-immunoprecipitation (TOB1-Smad4/5), lentiviral overexpression/knockdown, Tob1−/− mouse colitis models (TNBS enema, Rag1−/− reconstitution), RNA sequencing\",\n      \"journal\": \"Cellular and molecular gastroenterology and hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP for protein interaction, multiple in vivo genetic models, RNA-seq for downstream target identification; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"34920145\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Tob1 protein is localized to the nucleus and contains a sequence rich in proline and glutamine typical of transcription factors. The mouse tob gene lacks introns in its coding region and is ubiquitously expressed. The ATTTA motif in the 3'-UTR is characteristic of immediate early genes.\",\n      \"method\": \"Molecular cloning, Northern blot, sequence analysis\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — sequence analysis and expression data only; no direct functional experiment\",\n      \"pmids\": [\"9210596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TOB1 localization is mainly cytoplasmic in pancreatic cancer cells. Foxa2 overexpression significantly enhanced TOB1 promoter activity by binding to the TOB1 promoter (luciferase reporter assay), placing Foxa2 as a transcriptional activator of TOB1.\",\n      \"method\": \"Dual-luciferase reporter assay, immunofluorescence localization\",\n      \"journal\": \"Cancer medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single reporter assay and localization imaging; single lab, limited mechanistic depth\",\n      \"pmids\": [\"31891232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TOB1 is associated with P-body marker Dcp2 in round spermatids and oocytes, as shown by co-immunofluorescence and protein co-expression analysis. TOB1 protein is highly expressed in round spermatids and oocytes, consistent with a post-transcriptional regulatory role in germ cells.\",\n      \"method\": \"Immunofluorescence, RT-ddPCR, co-localization microscopy\",\n      \"journal\": \"Cell and tissue research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — colocalization by immunofluorescence without functional validation of Tob1-Dcp2 interaction; single study\",\n      \"pmids\": [\"26662055\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TOB1 is an antiproliferative protein that inhibits cell growth through at least two mechanistically distinct pathways: (1) as a transcriptional corepressor, it associates with receptor-regulated Smads (Smad1/2/4/5/8) and inhibitory Smads (Smad6/7) to suppress BMP/TGF-β signaling, with Smad4/5-dependent ID2 induction restraining Th17 differentiation, and recruits HDAC to suppress cyclin D1 transcription; (2) in the cytoplasm, it simultaneously binds Caf1 (CNOT7/CNOT8) deadenylase subunits of the CCR4-NOT complex (via its N-terminal BTG domain) and poly(A)-binding protein PABPC1 (via C-terminal PAM2 motifs), thereby recruiting deadenylase activity to the 3′ poly(A) tail to promote mRNA decay—a function further specified by interaction with CPEB3 for targeted mRNA regulation. TOB1 nucleo-cytoplasmic shuttling is governed by an N-terminal NES (residues 2–14) and a bipartite NLS (residues 18–40), and its anti-proliferative activity requires cytoplasmic access. Its stability and activity are regulated by phosphorylation: ERK1/2 and p90rsk1 phosphorylate Tob at C-terminal serines to inactivate its anti-proliferative function, while Skp2-SCF and Cul4-DDB1(Cdt2) E3 ubiquitin ligases mediate its proteasomal degradation—the latter being antagonized by Cdc7 kinase during the DNA damage response.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TOB1 is an antiproliferative protein that restrains cell growth through two mechanistically distinct activities: control of mRNA stability in the cytoplasm and transcriptional corepression in the nucleus [#16, #7]. As an adaptor for mRNA decay, TOB1 uses its structured N-terminal BTG-Tob domain to bind the Caf1 deadenylase subunits CNOT7/CNOT8 of the CCR4-NOT complex, while its unstructured C-terminal region carries two PAM2 motifs that engage cytoplasmic poly(A)-binding protein PABPC1; by bridging these partners it recruits deadenylase activity to the 3' poly(A) tail and accelerates mRNA decay, localizing to P-bodies in doing so [#14, #16, #17]. This tethered deadenylation is the basis of its growth-suppressive role, and a Caf1-binding mutant loses antiproliferative activity [#16, #19]; the activity directs decay of specific transcripts, including CPEB3-targeted mRNAs through a CPEB3-TOB1-Caf1 ternary complex and Id3 mRNA in embryonic stem cells [#18, #28]. In a parallel nuclear pathway, TOB1 associates with receptor-regulated Smads (Smad1/5/8) and inhibitory Smads (Smad6/7) to suppress BMP/TGF-beta signaling, with Smad4/5-dependent ID2 induction restraining Th17 differentiation and intestinal inflammation, and it represses cyclin D1 transcription via histone deacetylase recruitment to act upstream of Rb [#1, #8, #29, #7, #4]. TOB1 function is gated by phosphorylation: ERK1/2 and p90rsk1 phosphorylate C-terminal serines (Ser152/154/164) to inactivate its antiproliferative output, and the deadenylation activity is separable from these sites [#4, #5, #20]. Its abundance is controlled by ubiquitin-proteasome turnover through Skp2-SCF and Cul4-DDB1(Cdt2) ligases, the latter antagonized by Cdc7 kinase to stabilize TOB1 during the DNA damage response and block apoptosis [#12, #25, #26]. Nucleocytoplasmic shuttling governed by an N-terminal NES and a bipartite NLS positions TOB1 for its cytoplasmic function, which requires cytoplasmic access [#9, #10].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established TOB1 as a growth-suppressing protein and linked it to receptor tyrosine kinase signaling by identifying its physical association with ErbB2.\",\n      \"evidence\": \"GST pull-down, reciprocal Co-IP, and growth suppression assay in NIH3T3 cells\",\n      \"pmids\": [\"8632892\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the biochemical mechanism of growth suppression\", \"ErbB2 binding region mapped only to the C-terminal half\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Connected TOB1 to the CCR4 deadenylase machinery and cell cycle control by mapping the Caf1 interaction to the N-terminal half.\",\n      \"evidence\": \"Co-IP and protein interaction assays with cell cycle analysis\",\n      \"pmids\": [\"10602502\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of Caf1 binding for mRNA decay not demonstrated\", \"Single lab, two methods\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Defined a nuclear, signaling-suppressive function by showing TOB1 binds receptor-regulated Smads and restrains BMP-driven osteoblast proliferation in vivo.\",\n      \"evidence\": \"Co-IP, immunofluorescence, reporter assays, and tob knockout mouse bone phenotype\",\n      \"pmids\": [\"11163184\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Smad binding reflects corepressor activity at target promoters not resolved\", \"Relationship to cytoplasmic deadenylation function unaddressed\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Extended the Smad-associated function to immune quiescence, showing TOB1 enhances Smad DNA-binding at the IL-2 promoter to suppress T cell proliferation.\",\n      \"evidence\": \"Co-IP, EMSA, reporter assay, antisense loss-of-function and proliferation assays in T cells\",\n      \"pmids\": [\"11694881\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct DNA contact by TOB1 vs Smad-mediated effect not separated\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Began defining phospho-regulation of TOB1 by identifying p90rsk1 as a binding kinase downstream of receptor tyrosine kinases.\",\n      \"evidence\": \"In vitro kinase assay, Co-IP, chromatographic co-fractionation\",\n      \"pmids\": [\"11260258\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo phosphorylation evidence indirect\", \"Functional readout of p90rsk1 phosphorylation not established\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Established ERK1/2 phosphorylation of C-terminal serines as the switch that inactivates TOB1's antiproliferative function, placing TOB1 upstream of Rb via cyclin D1 suppression.\",\n      \"evidence\": \"In vitro kinase assay, S-to-A/S-to-E mutagenesis, transformation and proliferation assays, tob-/- cells, cyclin D1 analysis\",\n      \"pmids\": [\"12050114\", \"12151396\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking phosphorylation to loss of cyclin D1 repression not resolved\", \"Whether phosphorylation affects deadenylation not addressed at this stage\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identified the C-terminal region as the determinant of TOB1's proteasomal instability, initiating the picture of regulated turnover.\",\n      \"evidence\": \"Proteasome inhibitor, ubiquitin co-expression, truncation/GFP-fusion stability assays\",\n      \"pmids\": [\"12135500\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Responsible E3 ligase not identified\", \"Degron sequence not mapped\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showed TOB1 acts as a transcriptional corepressor recruiting HDAC to the cyclin D1 promoter, with loss causing tumor predisposition.\",\n      \"evidence\": \"Reporter assay, Co-IP with HDAC, tob-/- tumor analysis, cyclin D1 mRNA measurement\",\n      \"pmids\": [\"12756225\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct promoter occupancy by TOB1 not shown\", \"Whether HDAC recruitment is Smad-dependent unclear\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Broadened the Smad axis by showing TOB1 binds inhibitory Smads 6/7 and enhances Smad6 docking to BMP receptors to inhibit signaling.\",\n      \"evidence\": \"Yeast two-hybrid, Co-IP, colocalization, Xenopus embryo and BMP reporter assays\",\n      \"pmids\": [\"12782279\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution relative to R-Smad binding not resolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined nucleocytoplasmic shuttling via an N-terminal NES and bipartite NLS and established that cytoplasmic access is required for antiproliferative activity.\",\n      \"evidence\": \"Leptomycin B, NES/NLS mutagenesis with strong exogenous signals, immunofluorescence, cell cycle analysis\",\n      \"pmids\": [\"15235587\", \"15051490\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cytoplasmic target driving growth arrest not yet identified at this point\", \"Regulation of shuttling by signaling incompletely defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Linked TOB1 to translational control by showing it binds poly(A)-binding proteins and abrogates iPABP-enhanced IL-2 mRNA translation.\",\n      \"evidence\": \"Expression library screen, Co-IP, GST pull-down, in vitro translation, anergic T cell Co-IP\",\n      \"pmids\": [\"15676026\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the effect is on translation vs deadenylation not separated here\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Unified the cytoplasmic mechanism, showing TOB1 simultaneously bridges CCR4-CAF1 and PABPC1 via distinct motifs to enhance deadenylation at P-bodies.\",\n      \"evidence\": \"GST pull-down, Co-IP, motif mutagenesis, Tet-off mRNA decay assay, immunofluorescence\",\n      \"pmids\": [\"17785442\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo target transcripts not yet identified\", \"Quantitative kinetics of recruitment not measured\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Provided structural resolution of the TOB1-Caf1 interface and showed complex formation, not Caf1 catalysis, is what matters for growth inhibition.\",\n      \"evidence\": \"X-ray crystallography of N-terminal TOB1 bound to hCaf1, plus mutant growth assays\",\n      \"pmids\": [\"19276069\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the C-terminal PABPC1-binding region not in this work\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Quantified the binding architecture and proposed a thermodynamic competition model for recruiting deadenylase to the poly(A) tail after translation termination.\",\n      \"evidence\": \"NMR spectroscopy, Western quantification, Kd determination\",\n      \"pmids\": [\"20595394\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Competition model with eRF3 not validated in cells\", \"Single lab\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrated target-specific decay by showing TOB1 forms a CPEB3-TOB1-Caf1 ternary complex to accelerate deadenylation of CPEB3 target mRNAs.\",\n      \"evidence\": \"Co-IP, GST pull-down, in vitro deadenylation, dominant-negative mutants\",\n      \"pmids\": [\"21336257\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous CPEB3 target transcripts not enumerated\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Separated TOB1's two activities, showing tethered deadenylation depends on Caf1a/Caf1b and is independent of the ERK phosphorylation sites controlling antiproliferation.\",\n      \"evidence\": \"MS2 tethering and decay assays, subunit-specific siRNA, mutagenesis, proliferation and translation assays\",\n      \"pmids\": [\"23236473\", \"22252318\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the two mechanisms are coordinated within a cell not resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Connected TOB1 to a tissue-level proliferative checkpoint by showing it binds Caf1 and Cdk1 in liver and restrains hepatocyte regeneration.\",\n      \"evidence\": \"Co-IP, kinase activity assay, Tob1-/- hepatectomy model\",\n      \"pmids\": [\"20513747\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs deadenylation-mediated effect on Cdk1 unclear\", \"Single lab\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified the Cul4-DDB1(Cdt2) degradation route and its antagonism by Cdc7, linking TOB1 stability to survival during DNA damage.\",\n      \"evidence\": \"In vitro kinase assay, Co-IP, ubiquitination assay, Cdc7 siRNA, viability assay\",\n      \"pmids\": [\"23066029\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Pro-apoptotic signals suppressed by stabilized TOB1 not fully defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified Skp2-SCF as a primary E3 ligase for TOB1, coupling its degradation to cyclin D1 regulation.\",\n      \"evidence\": \"Co-IP, in vitro ubiquitination, Skp2-/- fibroblasts, siRNA, cyclin D1 assay\",\n      \"pmids\": [\"16951159\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phospho-dependence of Skp2 recognition not fully mapped\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established TOB1 as a stress-responsive node, showing its degradation underlies arsenite-induced inhibition of global mRNA deadenylation.\",\n      \"evidence\": \"siRNA phenocopy, poly(A) tail assay, protein degradation assay under arsenite\",\n      \"pmids\": [\"25446091\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Protease responsible for stress degradation not identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Tied TOB1-driven decay to a specific developmental program by showing Id3 mRNA degradation limits embryonic stem cell proliferation.\",\n      \"evidence\": \"Tob1/Tob2 knockout ESCs, proliferation and Id3 mRNA stability assays\",\n      \"pmids\": [\"25951976\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether Id3 is a direct vs indirect target not fully resolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Linked the Smad axis to an in vivo immune phenotype, showing TOB1-Smad4/5 induce ID2 to restrain Th1/Th17 differentiation and protect against colitis.\",\n      \"evidence\": \"Co-IP, lentiviral perturbation, Tob1-/- colitis models, RNA-seq\",\n      \"pmids\": [\"34920145\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding of TOB1-Smad complex at the ID2 locus not shown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the nuclear corepressor and cytoplasmic deadenylase functions are integrated, and what governs the choice between them in a given cell context, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No unified model coordinating shuttling, phosphorylation state, and the two effector pathways\", \"Genome-wide endogenous mRNA target set incompletely defined\", \"Whether Smad/HDAC corepression and deadenylation regulate overlapping gene sets unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [14, 16, 18]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [15, 16, 11]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [7, 2, 8]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [10, 14, 31]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 9, 30]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [14, 32]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [14, 16, 18]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 8, 4]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [7, 4, 21]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2, 29]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [7, 2]}\n    ],\n    \"complexes\": [\n      \"CCR4-NOT deadenylase complex\"\n    ],\n    \"partners\": [\n      \"CNOT7\",\n      \"CNOT8\",\n      \"PABPC1\",\n      \"CPEB3\",\n      \"SMAD4\",\n      \"SMAD6\",\n      \"ERBB2\",\n      \"SKP2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}